Back to Trades
Grant4
LEMAITRE VASCULAR INC
LMAT
Total Value
$2.6M
Company Information
- Company Name
- LEMAITRE VASCULAR INC
- Ticker Symbol
- LMAT
- CIK
- 0001158895
Insider Information
- Role
- Insider
- Location
- BURLINGTON, MA
Filing Details
- Filing Date
- Dec 15, 2025
- Transaction Date
- Dec 11, 2025
- Accession Number
- 0001193125-25-319553
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Dec 11, 2025 | Common Stock | 54 | — | Exercise | — |
| Dec 11, 2025 | Common Stock | 652 | $83.36 | Tax Withholding | $54.4K |
| Dec 12, 2025 | Common Stock | 5,155 | $37.29 | Exercise | $192.2K |
| Dec 12, 2025 | Common Stock | 7,733 | $48.60 | Exercise | $375.8K |
| Dec 12, 2025 | Common Stock | 7,075 | $47.19 | Exercise | $333.9K |
| Dec 12, 2025 | Common Stock | 6,182 | $54.65 | Exercise | $337.8K |
| Dec 12, 2025 | Common Stock | 12,100 | — | Bona Fide Gift | — |
| Dec 12, 2025 | Common Stock | 12,100 | — | Grant/Award | — |
| Dec 12, 2025 | Common Stock | 39 | — | Exercise | — |
| Dec 12, 2025 | Common Stock | 663 | $84.00 | Tax Withholding | $55.7K |
| Dec 12, 2025 | Common Stock | 39 | — | Exercise | — |
| Dec 12, 2025 | Common Stock | 663 | $84.00 | Tax Withholding | $55.7K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Dec 11, 2025 | Derivative | 54 | — | Exercise | — |
| Dec 12, 2025 | Derivative | 5,155 | $37.29 | Exercise | $192.2K |
| Dec 12, 2025 | Derivative | 7,733 | $48.60 | Exercise | $375.8K |
| Dec 12, 2025 | Derivative | 7,075 | $47.19 | Exercise | $333.9K |
| Dec 12, 2025 | Derivative | 6,182 | $54.65 | Exercise | $337.8K |
| Dec 12, 2025 | Derivative | 39 | — | Exercise | — |
| Dec 12, 2025 | Derivative | 39 | — | Exercise | — |
Footnotes
- (F1)Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
- (F2)These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/11/2021. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
- (F3)Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
- (F4)These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose.
- (F5)These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/12/2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
- (F6)These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on 12/12/2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
- (F7)These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- (F8)Fractional shares released (if any) on each vesting date were settled in cash, resulting in a final balance of zero.
- (F9)This option is fully vested and exercisable.
- (F10)This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years.
- (F11)These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- (F12)These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.